Diffusion tensor MRI as a biomarker in axonal and myelin damage

Imaging in Medicine

Volumn 5, Issue 5, 2013, Pages 427-440

  Aung, Wint Yan ^a   Mar, Soe ^b   Benzinger, Tammie Ls ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acute and chronic CNS disorders; acute disseminated encephalomyelitis; Alzheimers disease; axial diffusivity; axonal injury; diffusion tensor imaging; leukodystrophy; MRI; multiple sclerosis; myelin damage; radial diffusivity

Indexed keywords

NATALIZUMAB;

ALZHEIMER DISEASE; ANISOTROPY; ANTIINFLAMMATORY ACTIVITY; ASTROCYTOSIS; AXONAL INJURY; CELL INFILTRATION; CLINICAL PRACTICE; DEMYELINATING DISEASE; DEMYELINATION; DIFFUSION TENSOR IMAGING; DISEASE DURATION; DRUG EFFICACY; HUMAN; LEUKODYSTROPHY; MULTIPLE SCLEROSIS; MYELIN DAMAGE; NERVE CELL LESION; NERVE FIBER; NERVE FIBER DEGENERATION; NONHUMAN; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; PROGNOSIS; RETINA ISCHEMIA; REVIEW; TREATMENT RESPONSE; WALLERIAN DEGENERATION; WHITE MATTER LESION;

EID: 84885588592     PISSN: 17555191     EISSN: 17555205     Source Type: Journal    
DOI: 10.2217/iim.13.49     Document Type: Review

References (103)

1. Beaulieu C. The basis of anisotropic water diffusion in the nervous system-a technical review. NMR Biomed. 15(7-8), 435-455 (2002). (Pubitemid 36054508)
2. Beaulieu C, Allen PS. Water diffusion in the giant axon of the squid: implications for diffusion-weighted MRI of the nervous system. Magn. Reson. Med. 32(5), 579-583 (2005).
3. Basser PJ. New histological and physiological stains derived from diffusion-tensor mr images. Ann. NY Acad. Sci. 820(1), 123-138 (2006).
4. Benzinger TL, Cross AH, Xu J, Naismith R, Sun SW, Song SK. Directional diffusivity as a magnetic resonance (MR) biomarker in demyelinating disease. Proc. SPIE 6759, 67590O (2007).
5. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 20(3), 1714-1722 (2003). (Pubitemid 37468277)
6. Tyszka JM, Readhead C, Bearer EL, Pautler RG, Jacobs RE. Statistical diffusion tensor histology reveals regional dysmyelination effects in the shiverer mouse mutant. Neuroimage 29(4), 1058-1065 (2006). (Pubitemid 43184170)
7. Basser PJ. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed. 8(7), 333-344 (1995).
8. Xue R, van Zijl P, Crain BJ, Solaiyappan M, Mori S. In vivo three-dimensional reconstruction of rat brain axonal projections by diffusion tensor imaging. Magn. Reson. Med. 42(6), 1123-1127 (1999).
9. Filippi M, Rocca MA, Barkhof F et al. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol. 11(4), 349-360 (2012).
10. Filippi M, Agosta F. Imaging biomarkers in multiple sclerosis. J. Magn. Reson. Imaging 31(4), 770-788 (2010).
11. Sun SW, Liang H-F, Le TQ, Armstrong RC, Cross AH, Song SK. Differential sensitivity of in vivo and ex vivo diffusion tensor imaging to evolving optic nerve injury in mice with retinal ischemia. Neuroimage 32(3), 1195-1204 (2006). (Pubitemid 44278681)
12. Arfanakis K, Haughton VM, Carew JD, Rogers BP, Dempsey RJ, Meyerand ME. Diffusion tensor MR imaging in diffuse axonal injury. Am. J. Neuroradiol. 23(5), 794-802 (2002). (Pubitemid 34525695)
13. Beaulieu C, Does MD, Snyder RE, Allen PS. Changes in water diffusion due to Wallerian degeneration in peripheral nerve. Magn. Reson. Med. 36(4), 627-631 (2005).
14. Dijkhuizen RM, de Graaf RA, Tulleken KA, Nicolay K. Changes in the diffusion of water and intracellular metabolites after excitotoxic injury and global ischemia in neonatal rat brain. J. Cereb. Blood Flow Metab. 19(3), 341-349 (1999). (Pubitemid 30026924)
15. Sun SW, Liang HF, Trinkaus K, Cross AH, Armstrong RC, Song SK. Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn. Reson. Med. 55(2), 302-308 (2006). (Pubitemid 43238098)
16. Song SK, Yoshino J, Le TQ et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 26(1), 132-140 (2005).
17. Xie M, Tobin JE, Budde MD et al. Rostro-caudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features. J. Neuropathol. Exp. Neurol. 69(7), 704-716 (2010).
18. Zhang J, Jones MV, McMahon MT, Mori S, Calabresi PA. In vivo and ex vivo diffusion tensor imaging of cuprizone-induced demyelination in the mouse corpus callosum. Magn. Reson. Med. 67(3), 750-759 (2011).
19. Stidworthy MF, Genoud S, Suter U, Mantei N, Franklin RJ. Quantifying the early stages of remyelination following cuprizone-induced demyelination. Brain Pathol. 13(3), 329-339 (2003). (Pubitemid 36975823)
20. Harsan LA, Poulet P, Guignard B et al. Brain dysmyelination and recovery assessment by noninvasive in vivo diffusion tensor magnetic resonance imaging. J. Neurosci. Res. 83(3), 392-402 (2006). (Pubitemid 43184403)
21. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17(3), 1429-1436 (2002). (Pubitemid 35333862)
22. Fruttiger M, Montag D, Schachner M, Martini R. Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur. J. Neurosci. 7(3), 511-515 (2006).
23. Harsan LA, Poulet P, Guignard B, Parizel N, Skoff RP, Ghandour MS. Astrocytic hypertrophy in dysmyelination influences the diffusion anisotropy of white matter. J. Neurosci. Res. 85(5), 935-944 (2007). (Pubitemid 46580335)
24. Kim JH, Loy DN, Wang Q et al. Diffusion tensor imaging at 3 hours after traumatic spinal cord injury predicts long-term locomotor recovery. J. Neurotrauma 27(3), 587-598 (2010).
25. Liu M, Gross DW, Wheatley BM, Concha L, Beaulieu C. The acute phase of Wallerian degeneration. Longitudinal diffusion tensor imaging of the fornix following temporal lobe surgery. Neuroimage, 74, 128-139 (2013).
26. Xie M, Wang Q, Wu TH, Song SK, Sun SW. Delayed axonal degeneration in slow Wallerian degeneration mutant mice detected using diffusion tensor imaging. Neuroscience 197, 339-347 (2011).
27. Li J, Li XY, Feng DF, Gu L. Quantitative evaluation of microscopic injury with diffusion tensor imaging in a rat model of diffuse axonal injury. Eur. J. Neurosci. 33(5), 933-945 (2011).
28. Bennett RE, Mac Donald CL, Brody DL. Diffusion tensor imaging detects axonal injury in a mouse model of repetitive closed-skull traumatic brain injury. Neurosci. Lett. 513(2), 160-165 (2012).
29. Mar S, Lenox J, Benzinger T, Brown S, Noetzel M. Long-term prognosis of pediatric patients with relapsing acute disseminated encephalomyelitis. J. Child Neurol. 25(6), 681-688 (2010).
30. Mikaeloff Y, Suissa S, Vallée L et al. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J. Pediatr. 144(2), 246-252 (2004). (Pubitemid 38869403)
31. Neuteboom R, Boon M, Berrevoets CC et al. Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology 71(13), 967-973 (2008).
32. Verhey LH, van Pelt-Gravesteijn ED, Ketelslegers IA et al. Validation of MRI predictors of multiple sclerosis diagnosis in children with acute CNS demyelination. Mult. Scler. Relat. Disord. 2(3), 193-199 (2013).
33. Verhey LH, Branson HM, Shroff MM et al. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study. Lancet Neurol. 10(12), 1065-1073 (2011).
34. Stankiewicz J, Neema M, Alsop D et al. Spinal cord lesions and clinical status in multiple sclerosis. A 1.5 T and 3 T MRI study. J. Neurol. Sci. 279(1), 99-105 (2009).
35. Verhey LH, Branson HM, Makhija M, Shroff M, Banwell B. Magnetic resonance imaging features of the spinal cord in pediatric multiple sclerosis. a preliminary study. Neuroradiology 52(12), 1153-1162 (2010).
36. Dale R, Branson J. Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis? Arch. Dis. Child. 90(6), 636-639 (2005). (Pubitemid 40780729)
37. Coles AJ, Cox A, Le Page E et al. The window of therapeutic opportunity in multiple sclerosis. J. Neurol. 253(1), 98-108 (2006).
38. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Brück W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125(10), 2202-2212 (2002).
39. Schirmer L, Antel JP, Brück W, Stadelmann C. Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis. Brain Pathol. 21(4), 428-440 (2011).
40. Tallantyre EC, Bø L, Al-Rawashdeh O et al. Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis. Mult. Scler. 16(4), 406-411 (2010).
41. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338(5), 278-285 (1998). (Pubitemid 28065253)
42. Tillema J, Leach J, Pirko I. Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders. Mult. Scler. J. 18(12), 1754-1759 (2012).
43. Roosendaal S, Geurts J, Vrenken H et al. Regional DTI differences in multiple sclerosis patients. Neuroimage 44(4), 1397-1403 (2009).
44. Giorgio A, Palace J, Johansen-Berg H et al. Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis. J. Magn. Reson. Imaging 31(2), 309-316 (2010).
45. Henry RG, Oh J, Nelson SJ, Pelletier D. Directional diffusion in relapsing-remitting multiple sclerosis: a possible in vivo signature of Wallerian degeneration. J. Magn. Reson. Imaging 18(4), 420-426 (2003). (Pubitemid 37187594)
46. Kern KC, Sarcona J, Montag M, Giesser BS, Sicotte NL. Corpus callosal diffusivity predicts motor impairment in relapsing-remitting multiple sclerosis: a TBSS and tractography study. Neuroimage 55(3), 1169-1177 (2011).
47. Schmierer K, Wheeler-Kingshott CA, Tozer DJ et al. Quantitative magnetic resonance of post-mortem multiple sclerosis brain before and after fixation. Magn. Reson. Med. 59(2), 268-277 (2008). (Pubitemid 351220090)
48. Klawiter EC, Schmidt RE, Trinkaus K et al. Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords. Neuroimage 55(4), 1454-1460 (2011).
49. Audoin B, Ibarrola D, Malikova I et al. Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis-a two-year longitudinal MRI/MRSI study of corpus callosum. Mult. Scler. 13(1), 41-51 (2007). (Pubitemid 46152760)
50. Pelletier J, Suchet L, Witjas T et al. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Arch. Neurol. 58(1), 105-111 (2001). (Pubitemid 32053214)
51. Juha M, Leszek S, Sten F et al. Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development. J. Neurol. Neurosurg. Psych. 78(4), 375-380 (2007). (Pubitemid 46580545)
52. Dziedzic T, Metz I, Dallenga T et al. Wallerian degeneration: a major component of early axonal pathology in multiple sclerosis. Brain Pathol. 20(5), 976-985 (2010).
53. Deluca G, Ebers G, Esiri M. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain 127(5), 1009-1018 (2004). (Pubitemid 38623038)
54. Evangelou N, Deluca G, Owens T, Esiri M. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain 128(1), 29-34 (2005). (Pubitemid 40070517)
55. Gilmore CP, Deluca GC, Bö L et al. Spinal cord neuronal pathology in multiple sclerosis. Brain Pathol. 19(4), 642-649 (2009).
56. Fox R, Cronin T, Lin J et al. Measuring myelin repair and axonal loss with diffusion tensor imaging. Am. J. Neuroradiol. 32(1), 85-91 (2011).
57. Selewski D, Shah G, Segal B, Rajdev P, Mukherji S. Natalizumab (Tysabri). Am. J. Neuroradiol. 31(9), 1588-1590 (2010).
58. Fisher E, Chang A, Fox RJ et al. Imaging correlates of axonal swelling in chronic multiple sclerosis brains. Ann. Neurol. 62(3), 219-228 (2007). (Pubitemid 47525397)
59. Naismith R, Xu J, Tutlam N et al. Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole. Neurology 74(21), 1694-1701 (2010).
60. Moll NM, Rietsch AM, Thomas S et al. Multiple sclerosis normal-appearing white matter: pathology-imaging correlations. Ann. Neurol. 70(5), 764-773 (2011).
61. Laule C, Vavasour IM, Leung E et al. Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology. Mult. Scler. J. 17(2), 144-150 (2011).
62. Seewann A, Vrenken H, van der Valk P et al. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch. Neurol. 66(5), 601-609 (2009).
63. Freund P, Wheeler-Kingshott C, Jackson J, Miller D, Thompson A, Ciccarelli O. Recovery after spinal cord relapse in multiple sclerosis is predicted by radial diffusivity. Mult. Scler. 16(10), 1193-1202 (2010).
64. Lyon G, Fattal-Valevski A, Kolodny EH. Leukodystrophies: clinical and genetic aspects. Top. Magn. Reson. Imaging 17(4), 219-242 (2006). (Pubitemid 46594174)
65. Mar S, Noetzel M. Axonal damage in leukodystrophies. Pediatr. Neurol. 42(4), 239-242 (2010).
66. Ruest T, Holmes WM, Barrie JA et al. High-resolution diffusion tensor imaging of fixed brain in a mouse model of Pelizaeus-Merzbacher disease: comparison with quantitative measures of white matter pathology. NMR Biomed. 24(10), 1369-1379 (2011).
67. Regis S, Biancheri R, Bertini E et al. Genotype-phenotype correlation in five Pelizaeus-Merzbacher disease patients with PLP1 gene duplications. Clin. Genet. 73(3), 279-287 (2008). (Pubitemid 351228516)
68. Sima AA, Pierson CR, Woltjer RL et al. Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1. Acta Neuropathol. 118(4), 531-539 (2009).
69. Garbern JY, Yool DA, Moore GJ et al. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125(3), 551-561 (2002). (Pubitemid 34194410)
70. Nicchia G, Nico B, Camassa L et al. The role of aquaporin-4 in the blood-brain barrier development and integrity: studies in animal and cell culture models. Neuroscience 129(4), 935-944 (2004).
71. Jack C, Shiung M, Gunter J et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62(4), 591-600 (2004). (Pubitemid 38252801)
72. Juottonen K, Laakso M, Insausti R et al. Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease. Neurobiol. Aging 19(1), 15-22 (1998). (Pubitemid 28169839)
73. Berti V, Mosconi L, Glodzik L et al. Structural brain changes in normal individuals with a maternal history of Alzheimer's. Neurobiol. Aging 32(12), 2325.e17-e26 (2011).
74. Honea R, Swerdlow R, Vidoni E, Goodwin J, Burns J. Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology 74(2), 113-120 (2010).
75. Galton CJ, Patterson K, Graham K et al. Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. Neurology 57(2), 216-225 (2001). (Pubitemid 32667354)
76. Agosta F, Scola E, Canu E et al. White matter damage in frontotemporal lobar degeneration spectrum. Cerebral Cortex 22(12), 2705-2714 (2012).
77. Duning T, Warnecke T, Mohammadi S et al. Pattern and progression of white-matter changes in a case of posterior cortical atrophy using diffusion tensor imaging. J. Neurol. Neurosurg. Psych. 80(4), 432-436 (2009).
78. Hampel H, Teipel S, Alexander G, Pogarell O, Rapoport S, Möller HJ. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. J. Neural. Transm. 109(5-6), 837-855 (2002). (Pubitemid 34810777)
79. Huang J, Auchus AP. Diffusion tensor imaging of normal appearing white matter and its correlation with cognitive functioning in mild cognitive impairment and Alzheimer's disease. Ann. NY Acad. Sci. 1097(1), 259-264 (2007). (Pubitemid 47084896)
80. Gold BT, Powell DK, Andersen AH, Smith CD. Alterations in multiple measures of white matter integrity in normal women at high risk for Alzheimer's disease. Neuroimage 52(4), 1487-1494 (2010).
81. Smith CD, Chebrolu H, Andersen AH et al. White matter diffusion alterations in normal women at risk of Alzheimer's disease. Neurobiol. Aging 31(7), 1122-1131 (2010).
82. Lee J-T, Xu J, Lee J-M et al. Amyloid-b peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J. Cell Biol. 164(1), 123-131 (2004). (Pubitemid 38082463)
83. Roher AE, Weiss N, Kokjohn TA et al. Increased Ab peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry 41(37), 11080-11090 (2002). (Pubitemid 35034009)
84. Bartzokis G. Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol. Aging 32(8), 1341-1371 (2011).
85. Bartzokis G, Lu PH, Mintz J. Human brain myelination and amyloid beta deposition in Alzheimer's disease. Alzheimers Dement. 3(2), 122-125 (2007). (Pubitemid 46613474)
86. Acosta-Cabronero J, Alley S, Williams GB, Pengas G, Nestor PJ. Diffusion tensor metrics as biomarkers in Alzheimer's disease. PloS ONE 7(11), e49072 (2012).
87. Acosta-Cabronero J, Williams GB, Pengas G, Nestor PJ. Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. Brain 133(2), 529-539 (2010).
88. Pike C, Cummings B, Monzavi R, Cotman C. b-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 63(2), 517-531 (1994).
89. Santillo AF, Gambini JP, Lannfelt L et al. In vivo imaging of astrocytosis in Alzheimer's disease: an 11C-L-deuteriodeprenyl and PIB PET study. Eur. J. Nucl. Med. Mol. Imaging 38(12), 2202-2208 (2011).
90. Steele ML, Robinson SR. Reactive astrocytes give neurons less support: implications for Alzheimer's disease. Neurobiol. Aging 33(2), 423.e1-e13 (2012).
91. Zhang Y, Schuff N, Du AT et al. White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain 132(9), 2579-2592 (2009).
92. Stokin GB, Lillo C, Falzone TL et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307(5713), 1282-1288 (2005). (Pubitemid 40299973)
93. Wheeler-Kingshott CA, Cercignani M. About 'axial' and 'radial' diffusivities. Magn. Reson. Med. 61(5), 1255-1260 (2009).
94. Tournier JD, Mori S, Leemans A. Diffusion tensor imaging and beyond. Magn. Reson. Med. 65(6), 1532-1556 (2011).
95. Chung HW, Chou MC, Chen CY. Principles and limitations of computational algorithms in clinical diffusion tensor MR tractography. Am. J. Neuroradiol. 32(1), 3-13 (2011).
96. Poupon C, Roche A, Dubois J, Mangin JF, Poupon F. Real-time MR diffusion tensor and Q-ball imaging using Kalman filtering. Med. Image Anal. 12(5), 527-534 (2008).
97. Papadakis NG, Martin KM, Mustafa MH et al. Study of the effect of CSF suppression on white matter diffusion anisotropy mapping of healthy human brain. Magn. Reson. Med. 48(2), 394-398 (2002). (Pubitemid 34809430)
98. Falconer JC, Narayana PA. Cerebrospinal fluid-suppressed high-resolution diffusion imaging of human brain. Magn. Reson. Med. 37(1), 119-123 (1997). (Pubitemid 27008838)
99. Shimony JS, Mckinstry RC, Akbudak E et al. Quantitative diffusion-tensor anisotropy brain MR imaging: normative human data and anatomic analysis1. Radiology 212(3), 770-784 (1999). (Pubitemid 29410982)
100. Jones DK, Cercignani M. Twenty-five pitfalls in the analysis of diffusion MRI data. NMR Biomed. 23(7), 803-820 (2010).
101. Chou MC, Lin YR, Huang TY et al. FLAIR diffusion-tensor MR tractography: comparison of fiber tracking with conventional imaging. Am. J. Neuroradiol. 26(3), 591-597 (2005).
102. Pasternak O, Sochen N, Gur Y, Intrator N, Assaf Y. Free water elimination and mapping from diffusion MRI. Magn. Reson. Med. 62(3), 717-730 (2009).
103. Hermoye L, Saint-Martin C, Cosnard G et al. Pediatric diffusion tensor imaging: normal database and observation of the white matter maturation in early childhood. Neuroimage 29(2), 493-504 (2006). (Pubitemid 43063306)